For terminally ill cancer patients, the final days of life are immensely personal, having the choice to continue cancer treatments, or to stop treatments and prioritize a more comfortable passing. What a patient wants, however, isn’t always what they receive, according to a Rutgers Health study published in the journal Cancer.
“A patient’s end of life is often not a reflection of what they want, but rather, who their oncologist happens to be,” said Login S. George, a health services researcher at the Rutgers Institute for Health, Health Care Policy and Aging Research, and lead author of the national study. “The data doesn’t indicate patient-centered treatment decisions, but rather, more habitual or default ways of treating patients,” says George, who is also a member of the Cancer Prevention and Control Program at Rutgers Cancer Institute, the state’s only National Cancer Institute-designated Comprehensive Cancer Center.
Clinical guidelines for many cancers recommend stopping chemotherapy in the final days of life as it can do more harm than benefit. But while such treatment discontinuation decisions should be based on clinical presentation and patients’ preferences, oncologists could be making decisions based on their characteristic ways of proceeding in such contexts, George said. To read the full story.